newsfilter
← Latest News
GlobeNewswire·

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

VANCOUVER, British Columbia, July 12, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM), a research, development, manufacturing corporation specializing in the commercialization of rare cannabinoids, announces